Budas, Haniyya .
HRN: 26-27-63 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2025
CEFUROXIME 750MG (VIAL)
09/22/2025
09/29/2025
IV
300 Mg
Q 8 Hours
PCAP-C
Checking Initial Appropriateness
09/24/2025
MUPIROCIN 2%, 15G (TUBE)
09/24/2025
09/28/2025
TOPICAL
As Needed
BID
Skin Lesions
Checking Initial Appropriateness